Robert Hallenbeck is Vice President and General Counsel for Becton, Dickinson and Company.
Hallenbeck has overall responsibility for the Company's Law Group, Government Relations, Ethics and Business Practices, and Environmental Affairs and Safety. Hallenbeck joined Becton Dickinson in 1987 as a Patent Attorney, and spent six years in several roles of increasing responsibility in the Intellectual Property Department. In 1993, he was named Associate General Counsel and in February 1999 was named Assistant General Counsel.
Robert Hallenbeck received an undergraduate degree from St. Lawrence University. He holds a Master of Science degree in Biology and a Juris Doctor degree from Syracuse University.
Brian Qualey is the Branch Manager of Elmira Small Business Administration (SBA) Office.
Brian Qualey is a graduate of Elmira College.
Alan G. Hevesi was elected New York State Comptroller in 2002. Under his stewardship as sole trustee, the nation's second largest pension fund grew from $95 billion to $119.2 billion, a 29 percent gain, for the fiscal year ended March 31, 2004.
Some of the Comptroller's responsibilities include managing and protecting the state pension fund, auditing the spending practices of all state agencies and local governments, reviewing the New York State and City budgets, reviewing and approving all state contracts, and administering the State Oil Spill Fund.
Before his election as State Comptroller, Hevesi served two terms as New York City Comptroller. Under his stewardship, the city's pension funds grew from $49 billion to nearly $100 billion. Hevesi more than doubled the number of audits conducted by his Office, identifying hundreds of millions of dollars in savings.
Hevesi also spent 22 years in the State Assembly, where he authored 108 laws and established himself as a champion for affordable health care, education reform and the rights of people with disabilities.
Alan Hevesi holds a PH.D in Public Law & Government from Columbia University. He was a professor of political science at Queens College from 1967-1993, and was later an adjunct professor at Columbia University's School of International and Public Affairs and Fordham Law School.
Paul Wachtler is an independent medical device consultant.
H. Christopher Peterson is a professor in Agribusiness Management at Michigan State University. Prior to joining the faculty at MSU, Peterson served on the faculty and as chairperson for the Department of Economics and Business Administration at Juniata College.
Christopher Peterson received his Bachelor's degree from Juniata College, his MBA from Harvard University and his Ph.D. from Cornell University.
Bob Clark is President and Chief Executive Officer of Cooperative Business International, Inc. (CBI). In addition to 8 years as President and Chief Executive Officer of CBI, he has over 25 years of extensive experience and success as a Division Manager, Regional Manager, Turnaround Specialist and Vice President of International Operations for a $2.5 billion corporation.
Bob Clark received his undergraduate degree from The Ohio State University and his MBA from the University of Dayton.
Prem Das is Director of the Office of Technology Licensing & Industry Sponsored Research at Harvard University. Prior to joining OTL, Prem was Associate Director of the Office of Industrial Affairs at Memorial Sloan Kettering Cancer Center, and was Director of Business Development for Cadus Pharmaceuticals of Tarrytown, NY from 1996 until 1999. He worked with a start-up biotechnology company for several years prior to joining Cadus, first as Director of Research and subsequently as President and acting CEO. He has also worked as a business development consultant in the biochip area.
Prem Das received his Ph.D. in 1980 from the Chemistry Department at MIT and has academic research expertise in several areas of modern biology.
Frances Toneguzzo is currently the Director of the Office of Corporate Sponsored Research and Licensing at Massachusetts General Hospital. The Office of Corporate Sponsored Research and Licensing oversees the management and licensing of intellectual property and serves as the entry point for all industrial relationships relating to research, support of research or technology transfer at Massachusetts General Hospital.
Prior to coming to MGH, Toneguzzo served as Director of the Office for Technology and Industry Collaboration at Tufts University/New England Medical Center and as Associate Director, responsible for intellectual property relating to the life sciences at Harvard University. Toneguzzo comes from the biotech industry, having played various roles at big pharma and startup companies.
Frances Toneguzzo holds a Ph.D. in Biochemistry from McMaster University in Canada.
Todd Keiller is the Director of the Technology Transfer Office at the University of Vermont, Caritas St. Elizabeth's Medical Center of Boston, Boston Biomedical Research Institute, and Maine Medical Center. Mr. Keiller offers thirty years of experience in licensing, business development, and marketing. His work in the industrial sector includes ten years in the Science and Medical Products divisions of Corning Glass Works and encompassed a variety of sales, marketing, and business development roles. His fourteen years of academic licensing experience includes the position of Vice President for Ventures at the Brigham and Women's Hospital in Boston.
Mr. Keiller is a founder of six companies, most recently CorAutus (formerly Vascular Genetics, Inc.), a publicly traded gene therapy company; and Tolerance Pharmaceuticals, a diagnostic and therapeutic company recently acquired by Roche and focusing in transplantation and immunosuppression.
Todd Keiller received his MBA from the Tuck School of Business at Dartmouth and an A.B. degree from Dartmouth College.